| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |